These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26747471)

  • 41. MVL-PLA2, a phospholipase A2 from Macrovipera lebetina transmediterranea venom, inhibits tumor cells adhesion and migration.
    Bazaa A; Luis J; Srairi-Abid N; Kallech-Ziri O; Kessentini-Zouari R; Defilles C; Lissitzky JC; El Ayeb M; Marrakchi N
    Matrix Biol; 2009 May; 28(4):188-93. PubMed ID: 19351557
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biological and molecular properties of yellow venom of the Amazonian coral snake Micrurus surinamensis.
    Oliveira FDR; Noronha MDDN; Lozano JLL
    Rev Soc Bras Med Trop; 2017; 50(3):365-373. PubMed ID: 28700055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pseudechis australis venomics: adaptation for a defense against microbial pathogens and recruitment of body transferrin.
    Georgieva D; Seifert J; Öhler M; von Bergen M; Spencer P; Arni RK; Genov N; Betzel C
    J Proteome Res; 2011 May; 10(5):2440-64. PubMed ID: 21417486
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activity of two key toxin groups in Australian elapid venoms show a strong correlation to phylogeny but not to diet.
    Tasoulis T; Lee MSY; Ziajko M; Dunstan N; Sumner J; Isbister GK
    BMC Evol Biol; 2020 Jan; 20(1):9. PubMed ID: 31931699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contextual Constraints: Dynamic Evolution of Snake Venom Phospholipase A
    Suranse V; Jackson TNW; Sunagar K
    Toxins (Basel); 2022 Jun; 14(6):. PubMed ID: 35737081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Snake venomics of Micrurus alleni and Micrurus mosquitensis from the Caribbean region of Costa Rica reveals two divergent compositional patterns in New World elapids.
    Fernández J; Vargas-Vargas N; Pla D; Sasa M; Rey-Suárez P; Sanz L; Gutiérrez JM; Calvete JJ; Lomonte B
    Toxicon; 2015 Dec; 107(Pt B):217-33. PubMed ID: 26325292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A phospholipase A2 with anticoagulant activity. II. Inhibition of the phospholiped activity in coagulation.
    Boffa MC; Boffa GA
    Biochim Biophys Acta; 1976 May; 429(3):839-52. PubMed ID: 5143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pseudechis guttatus venom proteome: Insights into evolution and toxin clustering.
    Viala VL; Hildebrand D; Trusch M; Arni RK; Pimenta DC; Schlüter H; Betzel C; Spencer PJ
    J Proteomics; 2014 Oct; 110():32-44. PubMed ID: 25108201
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterisation of the heterotrimeric presynaptic phospholipase A(2) neurotoxin complex from the venom of the common death adder (Acanthophis antarcticus).
    Blacklow B; Escoubas P; Nicholson GM
    Biochem Pharmacol; 2010 Jul; 80(2):277-87. PubMed ID: 20361942
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure-function relationships and mechanism of anticoagulant phospholipase A2 enzymes from snake venoms.
    Kini RM
    Toxicon; 2005 Jun; 45(8):1147-61. PubMed ID: 15922780
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional involvement of Lys-6 in the enzymatic activity of phospholipase A2 from Bungarus multicinctus (Taiwan banded krait) snake venom.
    Chang LS; Kuo KW; Lin SR; Chang CC
    J Protein Chem; 1994 Oct; 13(7):641-8. PubMed ID: 7702746
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterisation of the biochemical and biological variations from the venom of the death adder species (Acanthophis antarcticus, A. praelongus and A. pyrrhus).
    van der Weyden L; Hains PG; Broady KW
    Toxicon; 2000 Dec; 38(12):1703-13. PubMed ID: 10858511
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The anticoagulant activity of Malayan cobra (Naja naja sputatrix) venom and venom phospholipase A2 enzymes.
    Tan NH; Arunmozhiarasi A
    Biochem Int; 1989 Oct; 19(4):803-10. PubMed ID: 2619749
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-affinity selective inhibitor against phospholipase A2 (PLA2): a computational study.
    Chinnasamy S; Chinnasamy S; Muthusamy K
    J Recept Signal Transduct Res; 2016; 36(2):111-8. PubMed ID: 26422703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amino acid sequences of eight phospholipases A2 from the venom of Australian king brown snake, Pseudechis australis.
    Takasaki C; Yutani F; Kajiyashiki T
    Toxicon; 1990; 28(3):329-39. PubMed ID: 2343466
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of total protein and enzyme levels in successive regenerations of venom from individual coralsnakes.
    Kopper RA; Harper GR; Occidental M; Gamalie V; Spradley P
    Toxicon; 2015 Jul; 101():19-22. PubMed ID: 25935458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Putting the brakes on snake venom evolution: the unique molecular evolutionary patterns of Aipysurus eydouxii (Marbled sea snake) phospholipase A2 toxins.
    Li M; Fry BG; Kini RM
    Mol Biol Evol; 2005 Apr; 22(4):934-41. PubMed ID: 15635056
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mulga snake (Pseudechis australis) envenoming: a spectrum of myotoxicity, anticoagulant coagulopathy, haemolysis and the role of early antivenom therapy - Australian Snakebite Project (ASP-19).
    Johnston CI; Brown SG; O'Leary MA; Currie BJ; Greenberg R; Taylor M; Barnes C; White J; Isbister GK;
    Clin Toxicol (Phila); 2013 Jun; 51(5):417-24. PubMed ID: 23586640
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of chemical modifications of Pa-11, a phospholipase A2 from the venom of Australian king brown snake (Pseudechis australis), on its biological activities.
    Takasaki C; Sugama A; Yanagita A; Tamiya N; Rowan EG; Harvey AL
    Toxicon; 1990; 28(1):107-17. PubMed ID: 2109907
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Production in Escherichia coli, folding, purification and characterization of notexin with wild type sequence and with N-terminal and catalytic site mutations.
    Simonato M; Morbiato L; Zorzi V; Caccin P; Fernández J; Massimino ML; Polverino de Laureto P; Tonello F
    Toxicon; 2014 Sep; 88():11-20. PubMed ID: 24951874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.